» Articles » PMID: 30894469

Herpes Simplex Virus 2 in Autonomic Ganglia: Evidence for Spontaneous Reactivation

Overview
Journal J Virol
Date 2019 Mar 22
PMID 30894469
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Herpes simplex virus 2 (HSV-2) can be transmitted in the presence or absence of lesions, allowing efficient spread among the general population. Recurrent HSV genital lesions are thought to arise from reactivated latent virus in sensory cell bodies of the dorsal root ganglia (DRG). However, HSV-2 has also been found latent in autonomic ganglia. Spontaneous reactivation or a low level of chronic infection could theoretically also occur in these peripheral nervous tissues, contributing to the presence of infectious virus in the periphery and to viral transmission. Use of a recently described, optimized virus with a monomeric mNeonGreen protein fused to viral capsid protein 26 (VP26) permitted detection of reactivating virus in explanted ganglia and cryosections of DRG and the sacral sympathetic ganglia (SSG) from latently infected guinea pigs. Immediate early, early, and late gene expression were quantified by droplet digital reverse transcription-PCR (ddRT-PCR), providing further evidence of viral reactivation not only in the expected DRG but also in the sympathetic SSG. These findings indicate that viral reactivation from autonomic ganglia is a feature of latent viral infection and that these reactivations likely contribute to viral pathogenesis. HSV-2 is a ubiquitous important human pathogen that causes recurrent infections for the life of its host. We hypothesized that the autonomic ganglia have important roles in viral reactivation, and this study sought to determine whether this is correct in the clinically relevant guinea pig vaginal infection model. Our findings indicate that sympathetic ganglia are sources of reactivating virus, helping explain how the virus causes lifelong recurrent disease.

Citing Articles

The opportunities and challenges of epigenetic approaches to manage herpes simplex infections.

Saddoris S, Schang L Expert Rev Anti Infect Ther. 2024; 22(12):1123-1142.

PMID: 39466139 PMC: 11634640. DOI: 10.1080/14787210.2024.2420329.


Models of Herpes Simplex Virus Latency.

Canova P, Charron A, Leib D Viruses. 2024; 16(5).

PMID: 38793628 PMC: 11125678. DOI: 10.3390/v16050747.


[Herpes simplex factors: Literature review].

Begazo L, Morante A, Espinoza Montes C Rev Cient Odontol (Lima). 2024; 10(1):e099.

PMID: 38389913 PMC: 10880724. DOI: 10.21142/2523-2754-1001-2022-099.


Mouse Models for Human Herpesviruses.

Kutle I, Dittrich A, Wirth D Pathogens. 2023; 12(7).

PMID: 37513800 PMC: 10384569. DOI: 10.3390/pathogens12070953.


A Case of Herpes Zoster Ophthalmicus in a Recently Transplanted Renal Patient.

Jabin M, Alam Z, Chung E, Shalabi M, Siddiqui B Cureus. 2023; 15(6):e40899.

PMID: 37492822 PMC: 10365146. DOI: 10.7759/cureus.40899.


References
1.
Kesson A . Management of neonatal herpes simplex virus infection. Paediatr Drugs. 2001; 3(2):81-90. DOI: 10.2165/00128072-200103020-00001. View

2.
Labetoulle M, Maillet S, Efstathiou S, Dezelee S, Frau E, Lafay F . HSV1 latency sites after inoculation in the lip: assessment of their localization and connections to the eye. Invest Ophthalmol Vis Sci. 2002; 44(1):217-25. DOI: 10.1167/iovs.02-0464. View

3.
Parr M, Parr E . Intravaginal administration of herpes simplex virus type 2 to mice leads to infection of several neural and extraneural sites. J Neurovirol. 2003; 9(6):594-602. DOI: 10.1080/13550280390246499. View

4.
Sawtell N, Thompson R . Comparison of herpes simplex virus reactivation in ganglia in vivo and in explants demonstrates quantitative and qualitative differences. J Virol. 2004; 78(14):7784-94. PMC: 434126. DOI: 10.1128/JVI.78.14.7784-7794.2004. View

5.
Rodahl E, Stevens J . Differential accumulation of herpes simplex virus type 1 latency-associated transcripts in sensory and autonomic ganglia. Virology. 1992; 189(1):385-8. DOI: 10.1016/0042-6822(92)90721-z. View